Eloxx Pharmaceuticals, Inc. ELOX
- ZKN-013 — Recessive Dystrophic Epidermolysis Bullosa Phase 1
- ZKN-013 — Junctional Epidermolysis Bullosa Phase 1
LAMB3 (1 companies · 2 programs)
Companies with an active program directed at LAMB3.
Companies with an active program directed at LAMB3.